Laboratory Medicine Program

Glioma: MGMT promoter methylation

Clinical Decription:
Methylation of the MGMT promoter in tumor tissue is associated with response to treatment with alkylating agents in glioma. MGMT promoter methylation is detected by pyrosequencing of DNA from a specific region in the promoter after bisulfite conversion.

Method: PCR-MLPA/MS-MLPA

Component Tests Used: n/a

Reference Ranges Used:
Reference ranges for this test are not available online. However, they are included in all test results. For more information, please call us.

Specimen Type: Paraffin-embedded material (FFPE)/Cytology fluids
Volume: n/a

Shipping: room temperature or 4 degree

Special Instructions: This test will be billed to a hospital, referring laboratory, referring physician or medical group. See requisitions for the full list of available testing and special instructions.

Testing Schedule(s): Please call

Turnaround Time: None

For more information, call 416.340.5227 or 1.866.865.5227